Back to search
FDAFDA · Food and drugs·Recall number D-1340-2022

Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661020846864.

Published July 27, 2022 · Recall initiated: June 27, 2022

Summary

FDA records drug Class II recall D-1340-2022, published July 27, 2022 and initiated June 27, 2022. Recalling firm: Loud Muscle Science; Status: Terminated; Reported quantity: 1500 10-count tins; Lot: Lot# C07172101, Exp date: 07/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Loud Muscle Science
Distributor
The product was distributed nationwide in the USA and Canada.
UPC
661020846864
Lot
Lot# C07172101, Exp date: 07/2024.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661020846864. recalled?

Yes. FDA published recall D-1340-2022 on July 27, 2022. Reported hazard: Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 661020846864.